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Abstract
Dopamine (DA) plays several important roles in the brain and body and has recently been used as a bioadhesive precursor for
medical applications. However, DA oxidizes immediately when exposed to oxygen and rapidly polymerizes into polydopamine
(PDA), leading to oxidative stress, cytotoxicity, and loss of DA functionalities. As a result, preventing rapid oxidation of DA is of
paramount importance but still remains a major challenge. Here, we report several strategies to impede DA oxidation in relevant
aqueous solutions (i.e., water, PBS, and cell culture media). One strategy is based on using reducing agents or antioxidants such
as glutathione in its reduced state (GSH) and sodium tetraborate (commonly known as borax). Another strategy is based on
nitrogenation, a method used to preserve DA in its reduced form by creating an oxygen-free environment. Our data suggest that
the antioxidant properties of GSH and borax substantially decreased DA oxidation for up to 2 months. Nitrogenation or oxygen
removal further prevented DA oxidation, enhancing its shelf life for longer periods of time. When tested with mammalian cells,
preventing DA oxidation with GSH dramatically improved viability of 3T3 fibroblasts and Tcells. These results demonstrate that
the use of antioxidants, alone or in combination with nitrogenation, can help prevent DA oxidation and improve its stability for
cell-based studies or for the design and development of biomaterials.
Keywords Dopamine . Oxidation . Reducing agents . Nitrogenation . Cytocompatibility
1 Introduction
Dopamine (DA), an innate catecholaminergic neurotransmit-
ter, and its oxidized derivatives, including polydopamine
(PDA), are of interest for their role in several biological pro-
cesses and diseases [1–5]. For instance, DA oxidation, low
DA concentrations, and high PDA concentrations are indica-
tors of neurological conditions, including Parkinson’s and
Alzheimer’s diseases [6]. Biological processes regulate DA
oxidation and its conversion into PDA to combat the onset
of these diseases [7]. In addition to these functionalities, evi-
dence from clinical studies in humans suggests that a subunit
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of melanin polymerizes into PDA, which causes dark pigmen-
tation on the skin, hair, and the substantia nigra of the brain
[8]. However, in other organisms such as mussels, PDA plays
a pivotal role in their adhesion in wet environments.
There are numerous reports on the rapid oxidation of DA
under physiological pH [5, 7, 9] and its effect on several pro-
cesses, including adhesiveness of biomaterials [5, 7, 10–12],
therapeutics [1–3], and conductive and adhesivematerial coat-
ings [4, 9, 13–15]. In the body, self-polymerization of DA into
PDA occurs in the presence of oxygen or monoamine oxidase
[10]. Furthermore, conversion of DA into PDA can be cata-
lyzed by an oxidizing agent such as sodium periodate. This
characteristic oxidation is qualitatively observed by the black-
ening of DA due to PDA formation, which has been associat-
ed with mammalian cell death [6, 8, 16–20]. There is a large
body of evidence suggesting that PDA formation leads to
oxidative stress–induced cytotoxicity due to the formation of
free radicals [21]. Specifically, it was found that DA oxidation
triggers apoptosis, while the use of antioxidants could prevent
DA-related cytotoxicity [22]. Furthermore, PDA formation
inhibits binding of DA to thiols, amines, and hydroxyls [10,
23]. Thus, there is an urgent need to develop or reinforce
strategies to control the rapid oxidation of DA.
To address this oxidative challenge, Han et al. recently
proposed a two-step polymerization technique to limit oxida-
tion of dopamine by encapsulating DA in clay interlayers
followed by controlled oxidation to form PDA [12].
However, steric hindrance and physical restrictions limited
the ability of DA to directly interact with tissues in this strat-
egy [12]. Here, we have investigated three facile routes to
prevent DA oxidation in relevant aqueous solutions (water,
phosphate buffered saline (PBS), and cell culture media).
Specifically, we hypothesize that both glutathione (GSH), an
antioxidant present in most mammalian tissues, and sodium
tetraborate (borax), a chemically inert antioxidant, can be used
independently and in combination with nitrogenation to pre-
serve DA in its reduced state for further chemical modifica-
tions or to limit oxidative stress–induced cell toxicity.
2 Results and discussion
2.1 Rate of DA oxidation and PDA formation
To determine the rate of DA oxidation and PDA formation
(Fig. 1), absorbance of unmodified DA in water, PBS (pH
7.4), and complete media were measured at various time
points. UV-vis data was utilized and the rate of DA oxidation
(rDA) was derived from a plot showing the percentage of ox-
idized DA as a function of time. Within 1 h, low levels of DA
oxidation were observed. The percentage of oxidation in wa-
ter, PBS, and cell culture media was quantified to be 18.6% ±
9.6%, 13.3% ± 1.7%, and 16.6% ± 1.9%, respectively (Fig. 2).
Prolonged incubation of DA-containing samples in their re-
spective solvents intensified oxidation. Specifically, the per-
centage of oxidized DA significantly increased to 71.6% ±
8.6%, 74.3% ± 19.3%, and 92.7% ± 1.0% in water, PBS, and
media, respectively, after 12 h.
Subsequently, the average reaction rate for DA oxidation at
37 °C was determined as shown in Eq. 1:
DA½  ¼ DA½ 0  ekDAt; kDA ¼ 3:28 10−3min−1 ð1Þ
The oxidation of unmodified DAwas visibly confirmed in
all tested solutions (Fig. 2). DA in water and PBS resulted in
76.9% ± 19.3% and 76.9% ± 8.7% oxidation within 24 h.
Interestingly, the highest oxidation rate was observed in cell
culture media, in which DA was almost completely oxidized
within the same time frame. These data can be fitted (correla-
tion factor > 0.98) to Eq. 1. Furthermore, it was observed that
DA consumption follows first-order kinetics as shown in Eq. 2:
A½  ¼ A½ 0 exp −katð Þ ð2Þ
In this equation, [A] is the final concentration of DA, [A]0 is
the starting concentration of DA, t is time, and ka is the rate
constant. The calculated kDA = 3.28 × 10
−3 ± 0.001.2 ×
10−3 min−1, where the rate constant is the average of the three
samples used and the error is the maximum deviation calcu-
lated with n = 3. The rate of oxidation is in line with the ap-
proximate simulated oxidation rate (rDA = 4 × 10
−3[DA]1/2)
[24]. To confirm this set of data, additional characterizations
by 1H nuclear magnetic resonance (NMR) spectroscopy
Raman spectroscopy Fourier-transform infrared (FTIR),
Spectroscopy and high-performance liquid chromatography
(HPLC) are presented in the Supplementary Information
(Figure S1 and Figure S2) [25]. In summary, these results
confirmed the instability and rapid oxidation of unmodified
DA and its conversion into PDA in various oxygen-containing
and antioxidant-free aqueous solutions.
2.2 Effect of antioxidants on DA oxidation
Three different strategies were proposed to prevent and limit
the rapid oxidation of DA. Specifically, nitrogenation was
employed, as well as reduction reactions using two commonly
used antioxidants, borax and GSH. These results were com-
pared with ascorbic acid (AA), a gold standard antioxidant
used here as a control. AA, also known as vitamin C, was
used as it is and the most widely used antioxidant in cell-
based in vitro studies. GSH was chosen for its high
cytocompatibility and strong ability to reduce oxidative stress
[26]. Although GSH has been used in a number of bioassays,
there is limited data on its application for the stabilization of
DA. Finally, borax is known to be toxic to cells, which limits
its application for in vitro and in vivo studies. However, it
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could be used to stabilize DA in chemical synthesis–related
applications. During the chemical modification of DA, borax
has been used as an alternative to GSH to prevent unwanted
competition between GSH and DA, as both contain similar
reactive groups.
To this end, the onset of DA oxidation was studied over a 2-
month period (56 days) and the results from both UV-vis
measurements and visual analysis are shown in Fig. 3 a (i)
and a (ii–iv), respectively. Briefly, 1 mM DA (1D, control),
1 mM DA supplemented with 20 mM GSH (D20G), and
1 mM DA supplemented with 20 mM borax (D20B) in PBS
were investigated for long-term stability at 37 °C. These sam-
ples were investigated with and without nitrogenation to de-
termine its efficacy in preventing DA oxidation. Samples were
tested at 1, 3, 7, 14, 28, and 56 days. These time points in a
geometric sequence were chosen to monitor DA oxidation
over 2 months in an exponential growth model. The concen-
trations of borax used in these studies were chosen based on its
solubility [27]. The use of higher concentrations resulted in
limited solubility and precipitation of the antioxidant. Our
results revealed a rapid oxidation of DA, reaching up to 90%
oxidation within 2 days (Fig. 3a(i)). Specifically, the UV-vis
measurements showed a total oxidation for 1D of 95.9% ±
4.1% and this was visually confirmed as presented in Fig.
3a(ii). Conversely, after 24 h, DA oxidation was significantly
reduced for D20B and D20G down to 3.2% ± 0.9% and nearly
0%, respectively. However, extended incubation for up to
56 days resulted in an increased oxidation of DA up to 21%.
In solution, both GSH and borax can dissociate hydrogen ions
to react with oxygen. This reaction is likely more favored than
the oxidation of DA, which follows a more complex route and
requires a higher activation energy [28].
These data suggest that both GSH and borax may be used
to retain DA in its reduced state. Furthermore, antioxidant-free
DA was found to darken quickly, which was consistent with
previously reported findings for DA oxidation and PDA for-
mation. However, based on our UV-vis data, even a slight
oxidation of DA resulted in darkening [9, 20, 23, 29].
The last technique employed was nitrogenation, an ap-
proach to exchange oxygen with nitrogen to prevent oxida-
tion. Although this method may not be suitable for cell-based
studies, simple chemical synthesis as well as long-term stor-
age of DA in different aqueous solutions may benefit from this
technique. Specifically, samples were purged with nitrogen for
approximately 30 min before and immediately after addition
of DA with or without antioxidants and subsequently moni-
tored for up to 2months. In comparison with non-nitrogenated
DA samples, all nitrogenated samples showed improved inhi-
bition of DA oxidation (< 2%) (Fig. 3b(i)). These results were
further confirmed visually, which is represented in Fig. 3b(ii–
iv). The slight oxidation of DA that was observed is likely due
to oxygen contamination during sample measurement and
handling. This demonstrated that nitrogenation may be suffi-
cient for retaining DA for an extended period of time. As a
control, these results were compared with a solution of 1 mM
DA supplemented with 1 mM AA (D1A), which has been
reported as the maximum amount of AA tolerated by mam-
malian cells [30]. In cell culture media, D1A resulted in visible
oxidation (33.1% ± 6.7%) as early as 24 h post-incubation.
Complete DA oxidation was observed after 6 days
(Figure S3). Remarkably, higher AA concentrations, equiva-
lent to D20G and D20B, still resulted in high DA oxidation.
Specifically, 1 mM DA supplemented with 20 mM AA
Fig. 2 DA readily oxidizes in different aqueous solutions: water, PBS,
and cell culture media. UV absorbance of DA, expressed as % oxidized
DA over time, is monitored at 530 nm using UV-vis spectroscopy. Values
represent mean and SD (n ≥ 3)
Fig. 1 Mechanisms of DA
oxidation and strategies to
prevent its alteration. Reaction
mechanism for DA oxidation and
subsequent polymerization
generating PDA, as well as a
strategy to retain DA in its
reduced state using a potent
antioxidant
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(D20A) resulted in 86.7% ± 6.1% DA oxidation after 6 days,
while only 5% of DA was oxidized for 20GSH (Figure S3).
Furthermore, 10mMGSH (10GSH) was also able to limit DA
oxidation to levels below 10%.
This was confirmed by an observed slower reaction rate
and rate constant (Eq. 3) of the DA oxidation reaction.
Overall, the DA oxidation rate used is as follows:
DA½  ¼ −1:51 10−5 DA½ 0; kDA;Overall of 1:51 10−5min−1
ð3Þ
Data was fit to a linear regression and by averaging the
slope from multiple experiments (n = 3) to ascertain
kDA,Overall. This result was also confirmed by enzyme-linked
immunosorbent assay (ELISA) (Figure S4). GSH concentra-
tions above 20 mM resulted in its precipitation and aggrega-
tion and were not further considered for this reason. It should
be noted that, for typical cell culture–related experiments, me-
dia is replaced within 5–7 days. This suggests that GSH may
be a suitable antioxidant for cell-based in vitro studies due to
its longer stability.
A schematic of the experimental setup to prevent DA oxi-
dation with GSH and nitrogenation can be found in Figs. 4 and
Figure S5, respectively. In particular, DA-containing samples
that were treated using nitrogenation could be stored for over
2 months. For short-term storage or the chemical modification
of DA, borax was a viable option for samples that are sensitive
to functionalities of GSH (e.g., thiol, amine, or carboxylic acid
groups). Specifically, for applications in Ni/Co supercapacitors
or Fe-based anodes in which DA is used as a carbon source,
controlling DA oxidation could have beneficial implications by
improving electron transfer within the carbon structures [31,
32]. In these cases, borax can act as an inexpensive antioxidant
for controlling DA functionalization or controlled polymeriza-
tion. Addition of GSH is a viable option for both long-term and
short-term sample preparation and storage for both benchtop
and in vitro experiments. For biological applications,
nitrogenation (or oxygen removal) is untenable, as it is condu-
cive to cell hypoxia and atrophy. Similarly, the toxicity of borax
limits its use for cell-based studies. Therefore, the use of GSH
as antioxidant should be considered for biological assays.
2.3 In vitro cytocompatibility of DA
Preventing DA oxidation is critical for a number of biomedi-
cal applications due to potential oxidative stress–induced cy-
totoxicity [33]. Thus, we investigated the impact of DAwhen
protected with an antioxidant (GSH) on the viability and met-
abolic activity of mammalian cells. To that end, 3T3 fibro-
blasts were cultured in complete cell culture media alone
(0D) or in combination with either 1 mM DA (1D), 1 mM
DA + 20 mMGSH (D20G), or 1 mMDA + 1 mMAA (D1A)
for 24 h at 37 °C. Prior to cell culture, these solutions were
Fig. 3 Prevention of DA
oxidation with antioxidants and
nitrogenation. a Plot of DA
oxidation in % with respect to
time. (i) Quantitative data
obtained from UVabsorbance at
530 nm to record DA oxidation
over time in normoxia.
Representative images of (ii) 1D:
1 mM DA in PBS, (iii) D20B:
1 mM DA in 20 mM borax, and
(iv) D20G: 1 mM DA in 20 mM
GSH on days 0 and 28. b
Quantitative data obtained from
UV-vis absorbance at 530 nm to
record DA oxidation over time in
an oxygen-free environment
(nitrogen purging).
Representative images of (ii) 1D:
1 mM DA in nitrogen-purged
PBS, (iii) D20B: 1 mM DA in
nitrogen-purged 20 mM borax,
and (iv) D20G: 1 mM DA in
nitrogen-purged 20 mM GSH on
days 0 and 56. Values represent
mean and SD (n ≥ 3)
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incubated for 1, 3, 5, 7, and 14 days at 37 °C. As expected,
antioxidant-free DA showed a high cytotoxicity with cell vi-
abilities of only 46.7% ± 2.11%, 15.8% ± 3.22%, and 11.1%
± 2.04% after 1, 3, and 5 days, respectively. Furthermore, all
cells died after 7 days (Fig. 5a, b), as compared with the
control (fibroblasts cultured in a DA-free media). Preventing
DA oxidation using 20 mM GSH significantly increased cell
viability to 87.3% ± 3.98%, 83.6% ± 6.97%, 78.3% ± 7.63%,
Fig. 5 GSH-protected DA retains high cell viability and metabolic
activity. a Confocal images of 3T3 fibroblasts showing fractions of live
(green) and dead (red) cells when cultured for 24 h in a DA-free cell
culture media (0D) or in cell culture media supplemented with 1 mM
DA (1D), 1 mM DA + 20 mM GSH (D20G), or 1 mM DA + 1 mM
AA (D1A). Pretreated DA solutions were allowed to sit for 1, 3, 5, 7, and
14 days prior to be mixed with the cell culture media and be exposed to
cells. b Quantification of 3T3 cell viability and (c) metabolic activity
following 24 h incubation with the following cell culture media: 0D,
1D, D20G, and D1A. The number sign means no cells. Values
represent mean and SD (n = 3). p < 0.05
Fig. 4 Glutathione (GSH)
prevents DA oxidation. a DA
oxidation in antioxidant-free
aqueous solutions leads to
neuromelanin pigment formation
and darkening. b GSH prevents
DA oxidation resulting in
colorless solutions, confirming
the stability of DA
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75.3% ± 8.85%, and 72.9% ± 3.32% after 1, 3, 5, 7, and
14 days of culture, respectively. Nevertheless, low levels of
cytotoxicity were observed. This was attributed to antioxidant
exhaustion over time leading to partial DA oxidation. This
was further evidenced by the negligible cytotoxicity observed
when 3T3 cells were cultured in DA-free media supplemented
with 20 mM GSH (20G) (Figure S6). Surprisingly, using
1 mM of AA (gold standard antioxidant) to prevent DA oxi-
dation did not improve cell viability but rather increased cell
death. Fibroblast viability was 4.03% ± 3.7%, 5.89% ±
2.31%, and 3.76% ± 2.64% after 1, 3, and 5 days, respectively.
Furthermore, all cells died after 7 days. This is likely due to
AA cytotoxicity, which is in accordance with the observed
poor 3T3 cell survival when cultured in DA-free media sup-
plemented with 1 mMAA (1A) (Figure S6). This observation
is also in agreement with previously published reports show-
ing the high cell toxicity and necrosis-mediated cell death
induced by AA concentrations between 1 and 4 mM [34].
To confirm these results, the metabolic activity of 3T3 fi-
broblasts was assessed over time as shown in Fig. 5c. Cells
were cultured in cell culturemedia supplemented withDA and
various antioxidants (0D, 1D, D20G, or D1A). Fibroblasts
treated with 1D dramatically reduced their metabolic activity
by 52.7%, 82.7%, 94.1%, and 100% after 1, 3, 5, and 7 and
14 days, respectively. However, cells treated with D20G sig-
nificantly improved cell metabolism, with up to 70% of met-
abolic activity preserved even after 14 days. In agreement with
the cell viability data, 1 mM AA even further reduced cell
metabolic activity when compared with 1D, with an 18-fold
and a 22-fold decrease after 1 day and 3 days, respectively.
The cytotoxicity of AA limited its use in biological systems at
concentrations that are effective to prevent DA oxidation.
Alternatively, GSH appeared to be a powerful and cell-
friendly antioxidant. This is probably due to the suppression
or reduction of DA-mediated oxidative stress by scavenging
free radicals such as reactive oxygen species (ROS). Oxidized
DA is known to trigger cytotoxicity and necrosis via deposi-
tion of DA quinone and other catechol derivatives on proteins,
altering their function [33].
Several studies have shown that DA is also a regulator of T
cell physiology and, in turn, immune responses [33, 35].
However, oxidation of DA resulted in the generation of
ROS, which are believed to alter T cell function and prolifer-
ation. For this reason, low concentrations of ROS are a pre-
requisite for maintaining T cell survival [35]. To demonstrate
the potential of GSH to prevent dopaminergic-triggered apo-
ptosis, murine spleen–derived primary T cells were cultured
(200,000 cells/mL, 1 mL per well of a 24-well plate) in com-
plete cell culture media alone (0D) or in combination with
either 1 mM DA (1D), 1 mM DA with 20 mM GSH
(D20G), or 1 mM DA supplemented with 1 mM AA (D1A).
Samples including 1D, D20G, and D1Awere incubated for 1,
3, and 5 days at 37 °C prior to being exposed to T cells. After
24 h of incubation, T cell viability was determined by flow
cytometry using a far-red fixable dead cell staining. While T
cells cultured in 0D maintained a high viability for 24 h, T
cells treated with 1D exhibited decreased cell viability, show-
ing nearly complete cell death after 5 days (Fig. 6a, b). As
expected, T cells cultured in the presence of D20G displayed
increased cell viability (> 80%), up to 821-fold when com-
pared with DA after 5 days of incubation. Conversely, T cells
treated with D1A showed a dramatic decrease in cell viability
with nearly complete cell death after 5 d of incubation. These
results are in agreement with the data on cytotoxicity and
metabolic activity of 3T3 cells, and further confirmed the ca-
pacity of GSH to prevent DA oxidation and ultimately oxida-
tive stress–induced cell death.
Fig. 6 GSH-protected DA preserves high T cell viability. a First, DA-
containing solutions were subjected to oxidation for 1, 3, and 5 days.
Next, T cells were incubated for 24 h with the pretreated DA-containing
conditions: DA-free RPMI media (0D, control) and in RPMI media
supplemented with 1 mM DA (1D), 1 mM DA + 20 mM GSH (D20G),
and 1 mM DA + 1 mMAA (D1A). b Representative histogram of CD3+
Tcell viability after 24 h of incubation in RPMI media that was pretreated
for 24 h with 1D, D20G, andD1A using far-red fixable dead staining. The
histograms show one representative experiment of triplicate treatment.
The number sign # means no cells. Values represent mean and SD (n =
3). p < 0.05
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3 Conclusion
Overall, we demonstrate three simple approaches to stabilize
DA and prevent or reduce its rapid oxidation. These strategies
are useful to extend DA lifetime and prevent oxidative stress
caused by its degradation. Our set of data demonstrates that
GSH, especially at high concentrations (up to 20 mM), sub-
stantially prevents oxidation of DA (up to 99%) without any
significant cytotoxicity. Unlike GSH, borax can provide a po-
tential substitute when an antioxidant is utilized in amine-
sensitive environments. Specifically, borax exhibits antioxi-
dant properties in radical-rich environments due to its affinity
for hydroxyl groups and its ability to form diester bridges
between cis-hydroxyl-containing molecules [36].
Comparatively, GSH involves the sulfhydryl group of the cys-
teine interacting with radicals [37]. Finally, nitrogenation pro-
vides a supplementary preventive option, reinforcing DA pro-
tection against oxidation for up to 2 months. The strategies to
prevent DA oxidation presented here can provide opportunities
to further understand the activity of DA in its intact reduced
state. The ability to prevent oxidation for extended periods of
time (> 2 weeks) while retaining cytocompatibility has the po-
tential to improve a number of biological studies, including
interactions of DA in the nervous system [35]. Finally,
preventing overoxidation of DA or its derivative, PDA, allows
these molecules to retain sufficient functional groups and ulti-
mately be used in tissue adhesive coatings and biomaterials
4 Materials and methods
4.1 Materials
Dopamine HCl, polydopamine, L-glutathione (98% purity;
C10H17N3O6S), L-ascorbic acid (C6H8O6), acetonitrile,
tetraflouroacetic acid (TFA), and trypsin-edta and DMSO-D6
were obtained fromMillipore-Sigma (Burlington, MA, USA).
Sodium tetraborate decahydrate (borax 99.5% purity,
Na2(B4O5(OH)4)·8H2O) was obtained from Thermo Fisher
Scientific (Waltham, MA, USA). All chemicals were used
without further purification. Dulbecco’s Modification of
Eagle’s Medium (DMEM) and Roswell Park Memorial
Institute (RPMI) medium were obtained from Corning Life
Sciences (Corning, NY, USA) and supplemented with 10%
v/v fetal bovine serum (Fisher Scientific), 100 μg/mL penicil-
lin (Fisher Scientific), and 100 μg/mL streptomycin (Fisher
Scientific) to form complete DMEM and RPMI cell culture
media (50 μM β-mercaptoethanol (Fisher Scientific)).
Fluorescent dyes, calcein AM and propidium iodide, were
both purchased from GeneCopoeia (Rockville, MD, USA).
Dopamine ELISA kit (KA1887) was obtained from Novus
Biologicals (Littleton, CO, USA). Tcell viability was analyzed
using flow cytometry (BD FACSCalibur DXPUpgraded, Cytek
Biosciences) using ViaQuant™ fixable red dead cell staining
(GeneCopoeia; Rockville, MD, USA) and anti-mouse CD3 an-
tibody (17A2, FITC). Fibroblast 3T3 cells were labeled using a
ViaQuant™ Viability/Cytotoxicity Kit for Animal Cells
(GeneCopoeia) using themanufacturer’s protocol by fluorescent
microscopy (Zeiss Axio Observer Z1 inverted microscope).
Finally, 3T3 cell metabolic activity was observed and were im-
aged using after 1-day treatment (total post-seeding time of
2 days) using Cell-QuantTM AlamarBlue Cell Viability
Reagent following manufacturer’s protocol.
4.2 1H NMR characterization of DA
Solutions of DA, PDA, and GSH in 1 mL DMSO-D6 were
each prepared in a Bruker Biospin disposable NMR tube fol-
lowing protocol developed elsewhere [10]. The respective 1H
NMR spectra were collected on a 400-MHz Varian NMR
spectrometer and evaluated by integrating peaks between
δ5.6 and 5.8 ppm, corresponding to CH (Figure S1a) of the
benzene ring, and peaks at δ1.8 and δ2.0 ppm, corresponding
to CH2 (Figure S1b, c) in DA. Similarly, shifts between δ6.5
and 7.5 ppm were assigned to the H surrounding both the
benzene and pyrrole functional groups [38]. Finally, a shift
at δ1.6 ppm corresponded to the hydrogen-amine bonds in
the alkene chain in DA and the hydrogen-nitrogen bonds in
the pyrrole group.
4.3 High-performance liquid chromatography of DA
To make a DA stock solution, 20 mg of DAwas dissolved in
1 mL of PBS and the pH was adjusted to 8.30 as previously
reported [25]. This stock solution was then diluted to make a
1 mM DA in PBS solution. In addition, both GSH (20 mM)
and control PDA (1 mM) were each dissolved in 1 mL of PBS.
The HPLC analyses were performed on an Agilent 1100 Series
HPLC with quaternary pump, auto sampler, and UV detector
equipped with a Discovery BIOWide Pore C18 HPLC column
(3-μm particle size; L, 5 cm; ID, 0.5 mm; Supelco Analytical a
Millipore-Sigma Division, Burlington, MA, USA). The mobile
phase was made up of MilliQ water with 0.1% TFA and ace-
tonitrile in 0.1% TFA in an optimized ratio of 30:70, respec-
tively. The various analytes were detected using UV-vis (280
nm) at a flow rate of 0.3 mL/min. Elution times for DA and
PDAwere detected at 5 min and 14.4 min, respectively, follow-
ing UV absorbance [25]. Amount of DA by percentage was
obtained by relating the relative intensities of each peak to a
known concentration (i.e., 1 mM DA).
4.4 Raman and Fourier-transform infrared
spectroscopy of DA oxidation
Raman spectroscopy was performed using a Thermo
Scientific DXR2xi Raman imaging microscope with an
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excitation wavelength of 785 nm, a resolution of 5 cm−1, and a
beam diameter of 10 mm. Spectra were evaluated at 1485 cm
−1 and 1525 cm−1 for the presence or disappearance of qui-
none and pyrrole groups, respectively. Fourier-transform in-
frared (FTIR) spectroscopy was obtained using a Bruker
Vertex 70 spectrometer. Spectra were evaluated at
2150 cm−1 and 3150–3600 cm−1 for the presence or disap-
pearance of the C–N–C and pyrrole groups, respectively.
4.5 DA oxidation study
Oxidation studies were conducted in 20-mL scintillation vials
equipped with rubber precision seal septum. Briefly, for the
controls, 1 mMDA± antioxidant was dissolved either in 5 mL
of water or PBS; after which, the vials were properly sealed.
Samples were then monitored over 56 days and samples were
collected for UV-vis analysis. Absorbance measurements of
samples were recorded at (day 0) and after 1, 3, 7, 14, 28, and
56 days and the percent of DA oxidation was calculated from
UVabsorbance at 530 nm. For nitrogenated samples, 5 mL of
water or PBS in scintillation vials was sealed with rubber seals
and subsequently purged with nitrogen for 30 min. A total of
1 mM DAwith or without antioxidants were then added into
the vials using a syringe followed by 30 min of purging with
nitrogen to ensure an oxygen-free sample prior to studies.
Samples were then monitored over 56 days and measured as
described above. A control sample containing 1 mM PDA in
PBS was taken as 100% oxidized. All absorbance values were
then scaled to control 1 mM PDA absorbance to represent
100% DA oxidation and the set of data was used to determine
corresponding oxidation kinetics.
4.6 DA enzyme-linked immunosorbent assay
After 1, 3, and 5 days of DA oxidation at 37 °C and humid-
ified at 5% CO2, 1 μL of a solution of 1 mL PBS with 1 mM
DA, 1mMDA supplemented with 20mMGSH, or 1 mMDA
supplemented with 1 mM AA was collected, diluted 1000×,
and then the concentration of DA was analyzed using a DA
ELISA kit, according to the manufacture’s guidelines.
4.7 DA stability in cell culture media
An assessment of DA stability was performed to evaluate the
potential oxidation of DA in media prior to any cytotoxicity
studies. Briefly, 1 mM DA solution was added to DMEM
containing different concentrations of GSH (1, 5, 10, and
20 mM) and AA (1 and 20 mM). Next, DA was monitored
both visually and by UV-vis spectroscopy at 530 nm over a 7-
day period. Plain media was used as control. Samples were
incubated at 37 °C with 5% CO2.
4.8 In vitro cytotoxicity studies
Mouse fibroblasts (NIH/3T3, CRL-1658, ATCC, Rockville,
MD, USA) were cultured in complete DMEM at 37 °C in a
humidified 5% CO2/95% air containing atmosphere.
Splenocytes were isolated from C57BL/6 mice and cultured
in complete RPMI. For viability studies, cells were seeded in a
24-well plate (200,000 cells/mL of complete media) for 24 h
prior to incubation with the different conditions. All DA-
containing conditions were subjected to oxidation for 1, 3,
and 5 days before utilization. Conditions were as follows: no
DA control (0D), 1 mM DA (1D), 1 mM DA with 10 mM
GSH (D10G), 1 mM DA with 20 mM GSH (D20G), 1 mM
DAwith 1 mM AA (D1A), and 1 mM DAwith 20 mM AA
(D20A). The conditions were prepared in appropriate media
(DMEM for fibroblasts, RPMI for T cells). Live/dead imaging
and viability was determined using a ViaQuant Viability/
Cytotoxicity Kit for Animal Cells (GeneCopoeia no. A017)
according to the manufacturer’s protocol. Briefly, post-incu-
bation for 24 h cells were washed with PBS and stained with
propidium iodide and calcein AM followed by more PBS
washing. The stained cells were immediately imaged on a
Zeiss Axio Fluorescent Microscope. Images were then proc-
essed via ImageJ image processing software to filter and count
stained cells. The percentage of viable cells was determined as
the ratio of viable cells to total number of cells. T cell viability
was analyzed using flow cytometry (BD FACS Calibur DXP
Upgraded, Cytek Biosciences) using ViaQuant™ fixable red
dead cell staining (GeneCopoeia; Rockville, MD, USA;
640 nm) and anti-mouse CD3 antibody (17A2, FITC;
488 nm). Cell metabolic activity (MA) was conducted using
a standard AlamarBlue assay (Thermo Fisher Scientific).
Briefly, 100 μL of media was removed from a 24-well plate
containing cells with media and replaced with 100 uL of
AlamarBlue. MA was measured via fluorescence at 530–
560 nm using an HTS-XT microplate reader.
4.9 Statistical analysis
Data analysis was carried out using a 1-way ANOVA test with
GraphPad Prism 6.0 software. Error bars represent mean ±
standard deviation (SD) of measurements (*p < 0.05,
**p < 0.01).
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